Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology
Crossref DOI link: https://doi.org/10.1007/s10549-017-4151-6
Published Online: 2017-02-15
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Inwald, EC http://orcid.org/0000-0001-8731-8481
Ortmann, O
Koller, M
Zeman, F
Hofstädter, F
Evert, M
Brockhoff, G
Klinkhammer-Schalke, M
License valid from 2017-02-15